Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Leica Biosystems

Sep 2013
Leica Biosystems of Newcastle upon Tyne, England, has acquired privately held Kreatech Diagnostics of Amsterdam, a provider of DNA fluorescence in situ hybridization probes and target labeling reagents, for an undisclosed amount. Kreatech will join Leica Biosystems’ Advanced Staining business unit, which is based in the UK. The combined business will develop targeted biomarker menus for Leica’s instrument platforms. The acquisition will enable a renewed focus on cytogenetics and anatomic pathology as well as on personalized medicine at research and drug development companies. Leica Biosystems is a provider of ThermoBrite and Bond systems for labeling tissue specimens for diagnostic interpretation in cytogenetics and pathology laboratories.

The emission of light or other electromagnetic radiation of longer wavelengths by a substance as a result of the absorption of some other radiation of shorter wavelengths, provided the emission continues only as long as the stimulus producing it is maintained. In other words, fluorescence is the luminescence that persists for less than about 10-8 s after excitation.
AmsterdamBasic ScienceBiophotonicsBusinessDNAEnglandEuropefluorescenceimagingKreatech DiagnosticsLeica BiosystemsRapidScan

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!